Patients Coming Off Weight-Loss Injections Gain Back Pounds Far More Rapidly Than People Using Diet and Exercise

Fresh analysis indicates that people who come off popular GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt traditional lifestyle programs.

Research printed in a leading medical journal demonstrates that while overweight individuals can lose a large proportion of their body weight while on the medication, the weight returns at an average rate of nearly a kilo each month after stopping.

"Individuals buying such drugs must be informed of the potential of quick rebound weight gain when the medication ends," stated expert Dr. Susan Jebb.

That rate of recovery means a reversion to pre-treatment mass within about 18 months.

Comparing Treatments

The research, which looked at dozens of studies involving thousands of patients, contrasted the results of these new drugs with older methods.

Researchers emphasize that people who lose weight through lifestyle changes alone typically experience a more gradual weight regain—around 0.1 kg a month—once they finish.

Understanding the Fast Rebound

Experts believe the mechanism of the injections explains the accelerated weight return.

The injections copy a body's own chemical called GLP-1, which controls appetite.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement means hunger is no longer kept in check, making overeating far more likely."

A Chronic Condition?

Health authorities advise the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, given the significant potential of relapse, the treatment is often life-long.

This opinion is supported by drug manufacturers, who note that the findings "emphasize the persistent character of excess weight," comparing it to managing diseases like high blood pressure.

Patient Testimonies

Individuals who have discontinued the jabs describe a intense resurgence of appetite.

"I experienced a switch that goes on and you're instantly extremely hungry," described an individual.

This difficulty is worsened if individuals have not adopted lasting dietary or behavioural modifications during therapy.

Widespread Interest

Figures suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.

• Use is more common among women compared to males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

Ultimately, researchers caution that while the jabs are effective agents for weight loss, they are not a standalone fix and long-term success likely depends on integrated behavioural management.